InformedDNA

An innovative, scalable precision health program for payors and employers, offering interactive education, clinical expert access, personalized summary reports, and dynamic educational content to guide personalized health choices based on genetics. Includes modules such as DNAimpact Metabolic for genetics-based weight management.

A no-cost genetic counseling and testing program for individuals with a family history of Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP), including single gene and panel testing, supported by Vigil Neuroscience, Inc.

A genetics-based weight management program integrating the MyPhenome genetic obesity test to guide personalized obesity care and treatment planning, including GLP-1 utilization, for payors, health systems, employers, and life sciences organizations.

A scalable precision health program for payors and employers, incorporating interactive education and access to clinical experts to guide personalized health choices based on genetics. The program includes personalized summary reports, dynamic educational content, and expert interpretation of genetic test results.

A solution designed to support patients and providers in navigating the genetic testing process, offering guidance and resources for informed decision-making.

Nationwide telehealth genetic counseling services, providing patients and providers with access to board-certified genetic counselors for screening, diagnosis, and treatment planning. Comprehensive coverage across all genetic specialties, with a patient-centric approach and no lab conflicts.

Expert solutions to identify and address overpayments and inappropriate spending in genetic testing programs, including claims analysis, coding review, and cost management strategies for health plans. Custom prepay and post-pay solutions ensure payment accuracy and minimize appeals.

Expert-led clinical trial recruitment and retention services, leveraging genetics expertise and counseling to accelerate eligible patient enrollment and improve retention in clinical trials. Includes patient identification, provider engagement, and compliance with data regulations.

Comprehensive utilization management services for genetic testing, including evidence-based coverage guidelines, case review, and policy development to optimize clinical decisions and reduce unnecessary testing. Intelligent prior authorization and decision support automation help prevent unnecessary spending.

CEO